Lista de obras -

A high mucosal blocking score is associated with HIV protection

artículo científico publicado en 2019

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

artículo científico publicado en 2012

Adaptive cell immune response against the hepatitis C virus infection

artículo científico publicado en 2007

An Additive Effect of Protective Host Genetic Factors Correlates With HIV Nonprogression Status ⬇️

artículo científico publicado el 1 de abril de 2011

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.

artículo científico publicado en 2013

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

artículo científico publicado en 2010

Both HCV Infection and Elevated Liver Stiffness Significantly Impacts on Several Parameters of T-Cells Homeostasis in HIV-Infected Patients

scientific article published on 15 September 2020

Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.

artículo científico publicado en 2017

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

artículo científico publicado en 2018

CD4 recovery is associated with genetic variation in IFNγ and IL19 genes

scientific article published on 03 August 2019

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.

artículo científico publicado en 2018

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

artículo científico publicado en 2012

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

artículo científico publicado en 2011

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b.

artículo científico publicado en 2012

Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

artículo científico publicado en 2010

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

artículo científico publicado en 2013

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

artículo científico publicado en 2010

Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.

artículo científico publicado en 2010

European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.

artículo científico publicado en 2014

Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years

artículo científico publicado en 2010

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.

artículo científico publicado en 2018

Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

artículo científico publicado en 2017

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

article

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

artículo científico publicado en 2017

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

article

HIV and malaria.

artículo científico publicado en 2007

HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality

artículo científico publicado en 2008

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.

artículo científico publicado en 2013

High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.

artículo científico publicado en 2018

Host factors involved in low susceptibility to HIV infection.

artículo científico publicado en 2011

Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.

artículo científico publicado en 2007

Human leucocyte antigen (HLA)-DQB103:02 and HLA-A02:01 have opposite patterns in their effects on susceptibility to HIV infection.

artículo científico publicado en 2017

IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.

artículo científico publicado en 2016

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.

artículo científico publicado en 2012

IL7RA rs6897932 Polymorphism is Associated with Better CD4+ T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy

artículo científico publicado en 2019

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

artículo científico publicado en 2011

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia.

artículo científico publicado en 2010

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

artículo científico publicado en 2011

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

artículo científico publicado en 2011

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.

artículo científico publicado en 2013

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

artículo científico publicado en 2011

Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection

article

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients

artículo científico publicado en 2020

Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors

artículo científico publicado en 2011

Longitudinal assessment of interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy

artículo científico publicado en 2011

Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.

artículo científico publicado en 2010

Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

article

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

artículo científico publicado en 2010

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

article

PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.

artículo científico publicado en 2014

Peering into the HIV reservoir

article

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

artículo científico publicado en 2017

Pharmacogenetics of hepatitis C.

artículo científico publicado en 2011

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

artículo científico publicado en 2011

Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.

artículo científico publicado en 2013

Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control

article

Rate and predictors of progression in elite and viremic HIV-1 controllers.

artículo científico publicado en 2016

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

artículo científico publicado en 2016

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

artículo científico publicado en 2015

Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.

artículo científico publicado en 2015

Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?

artículo científico publicado en 2012

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells

artículo científico publicado en 2008

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy.

artículo científico publicado en 2010

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

artículo científico publicado en 2015

The changing face of hepatitis C in the new era of direct-acting antivirals.

artículo científico publicado en 2012

The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

scientific article published on 01 November 2011

Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

scientific article published on 17 June 2020

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes

artículo científico publicado en 2011

[Factors involved in resistance to human immunodeficiency virus infection]

artículo científico publicado en 2011

Lista de obras de

A high mucosal blocking score is associated with HIV protection

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

Adaptive cell immune response against the hepatitis C virus infection

An Additive Effect of Protective Host Genetic Factors Correlates With HIV Nonprogression Status ⬇️

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

Both HCV Infection and Elevated Liver Stiffness Significantly Impacts on Several Parameters of T-Cells Homeostasis in HIV-Infected Patients

Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

CD4 recovery is associated with genetic variation in IFNγ and IL19 genes

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b.

Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.

European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.

Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.

Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

HIV and malaria.

HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.

High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.

Host factors involved in low susceptibility to HIV infection.

Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.

Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.

IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.

IL7RA rs6897932 Polymorphism is Associated with Better CD4+ T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia.

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients

Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors

Longitudinal assessment of interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy

Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.

Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.

Peering into the HIV reservoir

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

Pharmacogenetics of hepatitis C.

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.

Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control

Rate and predictors of progression in elite and viremic HIV-1 controllers.

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.

Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy.

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

The changing face of hepatitis C in the new era of direct-acting antivirals.

The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes

[Factors involved in resistance to human immunodeficiency virus infection]

Human leucocyte antigen (HLA)-DQB103:02 and HLA-A02:01 have opposite patterns in their effects on susceptibility to HIV infection.